Latest News

Stock Info

Price 0.435
Change 0.025 (6.10%)
Day Range 0.025
Week Range 0.38

Investor Relations

For media enquiries contact:

Josh Stanbury


Company Overview

Cognetivity Neurosciences Ltd. is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA) for use in medical and commercial environments. Cognetivity’s ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain, potentially allowing early diagnosis of dementia. Cognetivity aims to develop the ICA through planned clinical studies to the market in North America and Europe.

Download our latest deck here: Cognetivity deck 2018 

Sign up for updates